HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/5/C1275    most recent 00110.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (4) Citing Articles via Google Scholar Google Scholar Articles by Lansbery, K. L. Articles by Mercer, R. W. Search for Related Content PubMed PubMed Citation Articles by Lansbery, K. L. Articles by Mercer, R. W.

PROTEIN AND VESICLE TRAFFICKING, CYTOSKELETON

Cytoplasmic targeting signals mediate delivery of phospholemman to the plasma membrane

Department of Cell Biology and Physiology, Washington University School of Medicine, St. Louis, Missouri

Submitted 9 March 2005 ; accepted in final form 13 December 2005

The FXYD protein family consists of several small, single-span membrane proteins that exhibit a high degree of homology. The best-known members of the family include the -subunit of the Na⁺-K⁺-ATPase and phospholemman (PLM), a phosphoprotein of cardiac sarcolemma. Other members of the family include corticosteroid hormone-induced factor (CHIF), mammary tumor protein of 8 kDa (Mat-8), and related to ion channels (RIC). The exact physiological roles of the FXYD proteins remain unknown. To better characterize the function of the members of the FXYD protein family, we expressed several members of the family in Madin-Darby canine kidney (MDCK) cells. All of the FXYD proteins, with the exception of PLM, were primarily found in the basolateral plasma membrane. Surprisingly, PLM, a previously characterized plasma membrane protein, was found to colocalize with the endoplasmic reticulum marker protein disulfide isomerase. Treatment of MDCK cells expressing PLM with an agonist of PKC caused some of the PLM to be redistributed to the plasma membrane. Site-directed mutagenesis of residues within the cytoplasmic domain of PLM indicated that a negative charge at Ser69 is necessary to shift the localization of PLM to the plasma membrane. In addition, other regions of PLM necessary for either its endoplasmic reticulum or plasma membrane localization have been elucidated. In contrast to PLM, the plasma membrane localization of CHIF and RIC was not altered by mutation of potential cytoplasmic phosphorylation sites. Overall, these results suggest that phosphorylation of specific residues of PLM may direct PLM from an intracellular compartment to the plasma membrane.

protein trafficking; FXYD proteins

This article has been cited by other articles:

				W. Fuller, J. Howie, L. M. McLatchie, R. J. Weber, C. J. Hastie, K. Burness, D. Pavlovic, and M. J. Shattock FXYD1 phosphorylation in vitro and in adult rat cardiac myocytes: threonine 69 is a novel substrate for protein kinase C Am J Physiol Cell Physiol, June 1, 2009; 296(6): C1346 - C1355. [Abstract] [Full Text] [PDF]

				X.-Q. Zhang, J. Wang, L. L. Carl, J. Song, B. A. Ahlers, and J. Y. Cheung Phospholemman regulates cardiac Na+/Ca2+ exchanger by interacting with the exchanger's proximal linker domain Am J Physiol Cell Physiol, April 1, 2009; 296(4): C911 - C921. [Abstract] [Full Text] [PDF]

				E. Arystarkhova, C. Donnet, A. Munoz-Matta, S. C. Specht, and K. J. Sweadner Multiplicity of expression of FXYD proteins in mammalian cells: dynamic exchange of phospholemman and {gamma}-subunit in response to stress Am J Physiol Cell Physiol, March 1, 2007; 292(3): C1179 - C1191. [Abstract] [Full Text] [PDF]